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NADPH Oxidase–Dependent Superoxide Production Is
Associated With Carotid Intima-Media Thickness in
Subjects Free of Clinical Atherosclerotic Disease
Guillermo Zalba, Oscar Beloqui, Gorka San Jose´, Marı´a U. Moreno, Ana Fortun˜o, Javier Dı´ez
Objective—Oxidative stress plays a critical role in the pathogenesis of atherosclerosis. The NADPH oxidase constitutes the
main source of superoxide in phagocytic and vascular cells. This study aimed to investigate the levels of NADPH
oxidase–mediated superoxide production in phagocytic cells and the association between phagocytic superoxide
production and carotid intima-media thickness (IMT), a surrogate marker of asymptomatic atherosclerosis.
Methods and Results—NADPH oxidase–mediated superoxide production was determined by a chemiluminescence assay
using lucigenin and associated with IMT for 184 asymptomatic subjects free of overt clinical atherosclerotic disease.
Compared with individuals in the lowest tertile of superoxide production, those in the upper tertile (20 counts/sec)
showed significantly higher IMT (P0.05). In correlation analysis, a positive relationship was found between
superoxide production and carotid IMT. Superoxide production also correlated positively (P0.05) with body mass
index (BMI). In multivariate analysis, the association of superoxide production with carotid IMT remained significant
after adjustment for age, sex, systolic blood pressure, BMI, triglycerides, glucose, and smoking.
Conclusions—In a population sample of adults without clinically overt atherosclerotic disease, increased NADPH oxidase
activity was associated with enhanced carotid IMT, suggesting a relationship between phagocytic NADPH oxidase–
mediated oxidative stress and the development of atherosclerosis. (Arterioscler Thromb Vasc Biol. 2005;
25:1452-1457.)
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Oxidative stress, defined as an imbalance between oxi-dants and antioxidants in favor of the former, plays a
significant role in the pathogenesis of atherosclerotic vascular
disease.1 Traditionally, it has been accepted that reactive
oxygen species (ROS) are involved in low-density lipoprotein
oxidation, a key step in the initiation and progression of
atherosclerosis.2 More recently, ROS have been also impli-
cated in other pathological processes in the vessel wall,
including endothelial dysfunction, activation of matrix met-
alloproteinases, and vascular smooth muscle cell (VSMC)
migration, growth, and apoptosis.3 Taken together, ROS play
an integral role in the initiation, the progression, and the end
event of the atherosclerotic process.
The NADPH oxidase systems, which constitute the most
important source of superoxide (O2) in the vessel wall,
are present in endothelial cells, VSMCs, and fibroblasts.4
The structure of vascular NADPH oxidases is similar,
although differs structurally and biochemically, from the
phagocytic NADPH oxidase, an oxidase originally identi-
fied in the defense against exogenous microorganisms. The
phagocytic oxidase is a membrane-bound enzyme that
catalyzes the single electron reduction of molecular oxy-
gen to form O2. It consists of a membrane-associated
cytochrome b558, and 3 cytosolic components p47phox,
p67phox, and rac1/2. Cytochrome b558 comprises a large
subunit, gp91phox (also called Nox2), and a smaller subunit,
p22phox, and it functions as the final electron transporter
from NADPH to molecular oxygen.5 Although intensive
investigations have been conducted to identify the vascular
NADPH oxidases, their molecular characterization still
remains unclear. In the past years, 2 novel gp91phox/Nox2
homologues, Nox1 and Nox4, were identified in VSMCs
and represent functional oxidases.6 –9 More recently, it has
been shown that Nox4 functions as the major catalytic
component of endothelial NADPH oxidase.10
In the past years, several works have demonstrated a key
role of vascular NADPH oxidase isoforms in the develop-
ment of human atherosclerosis.11–15 Interestingly, it has been
also reported the contributing role of the infiltrated monocyte
NADPH oxidase in the development of the atherosclerotic
lesion.13–15 It is traditionally accepted that ROS generation
from infiltrated monocytes contributes to atherosclerotic le-
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sion formation.16 With this background, it might be suggested
that besides a major role of vascular NADPH oxidases,
phagocytic NADPH oxidase could play a significant role in
the development and progression of atherosclerotic lesion.
Available evidence substantiates that carotid intima-media
thickness (IMT), as measured by B-mode ultrasound, corre-
lates with the presence of coronary atherosclerosis17 and
represents an independent risk factor for atherothrombotic
events (ie, coronary heart disease events, stroke, and transient
cerebral ischemia).18–20 Thus, carotid ultrasound examination
and IMT measurement can provide a useful surrogate marker
for atherosclerotic disease.21 We have hypothesized that an
association may exist between phagocytic NADPH oxidase
activity and atherosclerosis in asymptomatic subjects. To test
this hypothesis, we have investigated the relationship be-
tween NADPH oxidase–mediated O2 production in phago-
cytic cells and carotid IMT in middle-aged adults with no past
or current medical history of atherosclerotic disease.
Patients and Methods
The study was performed in 184 consecutive apparently healthy
individuals (81% men, mean age 53.9 years) referred to our
institution for global cardiovascular risk assessment. Subjects were
free from clinically apparent atherosclerotic disease based on: (1)
absence of history of coronary disease, stroke, or peripheral artery
disease; and (2) normal electrocardiogram and chest-x-ray results.
Coronary heart disease was defined by: (1) self-reported myocardial
infarction, angina, or use of nitroglycerin; and (2) self-reported
history of coronary angioplasty or coronary artery bypass surgery.
Cerebrovascular disease was defined as self reported stroke, transient
ischemic attack, or carotid endarterectomy. Symptoms of intermit-
tent claudication were queried in a questionnaire, together with the
physician interview. Patients were also excluded if they had ad-
vanced carotid atherosclerosis according to IMT measurements
(1.7 mm). Additional exclusion criteria were the presence of
severely impaired renal function, arteritis, collagenosis, and a history
of alcohol abuse. Patients with significant acute infection, according
to clinical criteria by the attending physician, were also excluded.
Written informed consent was obtained from all subjects, the study
was performed in accordance with the Declaration of Helsinki, and
the local committee on human research approved of the study
protocol.
Assessment of Cardiovascular Risk Factors
The presence of cardiovascular risk factors such as diabetes mellitus,
arterial hypertension, dyslipidemia, obesity, and smoking habits
were also assessed (available online at http://atvb.ahajournals.org).
Determination of O2 Production
We measured O2 production in peripheral mononuclear cells
(lymphocytes and monocytes) isolated from blood samples with
Lymphoprep, in response to stimulation with phorbol myristate
acetate (PMA) (3.2106 mol/L), and using 10 mol/L lucigenin by
a chemiluminescence method as previously described.22 In some
experiments, the effect of 5 mol/L diphenylene iodonium, a
flavoprotein inhibitor, and 2.5103 mol/L apocynin, a specific
intracellular inhibitor of NADPH oxidase assembly, were studied. To
verify the specificity of the lucigenin assay for O2 generation in our
model, the effect of superoxide dismutase (SOD) 10 000 U/mL, an
enzymatic scavenger of O2, was also examined. Although lucigenin
concentration was low enough to avoid auto-oxidation, the measure-
ments were validated against an independent measurement of O2
production using SOD-inhibitable ferricytochrome c reduction
(available online). The measurement of O2 production using SOD-
inhibitable ferricytochrome c reduction closely correlated with lu-
cigenin measurements (Figure I, available online at http://atvb.
ahajournals.org). In some subjects, phagocytic O2 production was
evaluated in response to angiotensin II and endothelin 1.
Measurement of Carotid IMT
Ultrasonography of the common carotid arteries was performed with
a 5- to 12-MHz linear-array transducer (ATL 500 HDI). The
measurement of IMT was made 1 cm proximal to the carotid bulb of
each common carotid artery at plaque-free sites. For each individual,
the IMT was determined as the average of near wall and far wall
measurements of each common carotid artery. Subjects were exam-
ined by the same 2 certified sonographers blinded to all clinical
information. The reproducibility of IMT measurements between and
within sonographers had previously been checked in individuals who
returned 2 weeks later for a second examination.23 The intraobserver
and interobserver coefficients of variation were 5% and 10%,
respectively.
Statistical Analysis
Data are expressed as meanSEM. Differences in the baseline
characteristics of subjects classified according to tertiles of O2
production, in the O2 production of subjects classified according to
quartiles of carotid IMT, and in the O2 production of phagocytes in
response to different agonists were evaluated by ANOVA followed
by Tukey B post hoc test. The 2 analysis was used to search for
differences for qualitative variables. Pearson correlation test was
used to assess correlations between O2 production and all contin-
uous variables. Multivariate linear regression analysis was per-
formed to evaluate factors related to carotid IMT and the possibility
of interactions. All variables that were significantly correlated with
carotid IMT in the univariate analysis were included in the model.
The statistical analysis was performed with SPSS 11.0 for Windows.
Results
NADPH Oxidase–Dependent O2 Production
The PMA-stimulated O2 production was inhibited by diphe-
nylene iodonium, a flavoprotein inhibitor, and by apocynin, a
potent intracellular inhibitor of NADPH oxidase system more
specific than diphenylene iodonium (Figure I). Apocynin
impedes the assembly of the p47phox and p67phox subunits with
cytochrome b558, and it does not have known inhibitory
effects on the other potential enzymatic sources of ROS.24
Furthermore, SOD, a scavenger of O2, completely abolished
the chemiluminescence induced by PMA stimulation. These
results demonstrate that the enzymatic source of O2 in
phagocytic cells was the NADPH oxidase complex.
Angiotensin II (0.1 mol/L) and endothelin 1 (0.01 mol/L)
significantly stimulated the phagocytic NADPH oxidase–
mediated O2 production (basal, 1.000.04 counts/sec; angio-
tensin II, 1.780.09 counts/sec; endothelin 1, 1.650.06 counts/
sec) (Figure 1).
O2 Production: IMT Associations
The mean level of phagocytic O2 production was 18.6
counts/sec (range, 0.1 to 130 counts/sec). Table 1 shows the
demographic and clinical characteristics of subjects stratified
by tertiles of phagocytic NADPH oxidase–mediated O2
production. Subjects in the upper tertile of phagocytic O2
production exhibited an increased carotid IMT compared
with subjects in the medium and the lowest tertiles (P0.05).
Moreover, subjects in the upper tertile also had higher
systolic blood pressure, body mass index, glucose, and
triglycerides than subjects in the lowest tertile (P0.05). The
percentage of men was also significantly elevated in the
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upper tertile. No differences among tertiles were found for the
remaining characteristics tested.
There was a significant positive bivariate correlation be-
tween phagocytic O2 production and carotid IMT (r0.293,
P0.001) in all the subjects. As shown in Table 2, the
association between the 2 parameters remained highly signif-
icant (r0.248, P0.001) after controlling for age and sex.
Phagocytic O2 production was also significantly associated
with triglycerides (r0.159, P0.05) and body mass index
(r0.202, P0.01), with the latter also remaining statisti-
cally significant after controlling for age and sex.
Carotid IMT significantly correlated with age (r0.404,
P0.001), systolic blood pressure (r0.159, P0.05), glu-
cose (r0.278, P0.001), body mass index (r0.240,
P0.005), and triglycerides (r0.169, P0.05), with the 3
latter also remaining statistically significant after controlling
for age and sex (Table 3).
Because of the associations found of phagocytic O2
production and IMT with some cardiovascular risk factors, a
further multivariate analysis was performed to assess the
relationship between phagocytic O2 production and carotid
IMT after adjusting for these potential confounding factors
(Table 4). A significant association between phagocytic O2
production and IMT (P0.001) remained after adjusting for
all the potential confounding factors, with the O2 production
explaining up to 14.3% of the IMT variance after adjusting
for the effects of common risk factors. Besides this associa-
tion, we found that age also associated with IMT (P0.001)
independently of O2 production.
The distribution of O2 production by quartiles of carotid
IMT showed a significant difference in O2 production
(P0.05) between the quartiles of IMT (Figure 2); moreover,
Figure 1. Effects of angiotensin II and endothelin 1 on the
phagocytic NADPH oxidase–mediated O2 production. Baseline
and angiotensin II (0.1 mol/L) and endothelin 1 (0.01 mol/L)-
stimulated O2 generation in mononuclear cells obtained from
subjects. Data are expressed as meanSEM (n14). *P0.05
vs baseline.
TABLE 1. Baseline Characteristics of the Studied Population









Age, y 52.31.5 54.41.4 55.31.7
Sex, M/F 49/13 58/8* 48/8*
BMI, kg/m2 27.90.5 28.50.8 30.30.8*
SBP, mm Hg 1242 1362* 1332*
DBP, mm Hg 812 831 821
Subjects who smoke, % 29 32 32
Hypertensive subjects, % 44 61 62
Diabetic subjects, % 11 12 32*†
Obese subjects, % 24 30 44
Glucose, mg/dL 982 982 1063*†
Total cholesterol, mg/dL 2236 2255 2236
HDL cholesterol, mg/dL 471 451 451
LDL cholesterol, mg/dL 1525 1525 1515
Triglycerides, mg/dL 1005 1065 1175*
Carotid IMT, mm 0.670.01 0.660.01 0.720.02*†
BMI indicates body mass index; DBP, diastolic blood pressure; HDL,
high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood
pressure.
*P0.05 compared with the lowest tertile of O2 production.
†P0.05 compared with the middle tertile of O2 production.
TABLE 2. Correlation Between O2 Production and All Other
Parameters Evaluated
R P Rc Pc
Age, y 0.119 0.108 — —
BMI, kg/m2 0.202 0.009 0.167 0.032
SBP, mm Hg 0.141 0.059 0.102 0.172
DBP, mm Hg 0.024 0.747 0.047 0.528
Glucose, mg/dL 0.133 0.072 0.096 0.195
Total cholesterol, mg/dL 0.056 0.447 0.064 0.388
HDL cholesterol, mg/dL 0.096 0.202 0.089 0.235
LDL cholesterol, mg/dL 0.082 0.270 0.086 0.248
Triglycerides, mg/dL 0.159 0.043 0.140 0.077
Carotid IMT, mm 0.293 0.001 0.248 0.001
R and P values for bivariate correlations. Rc and Pc values of partial
correlations after controlling for age and sex.
TABLE 3. Correlation of the Carotid IMT With All Other
Variables Investigated
R P Rc Pc
Age, y 0.404 0.001 — —
BMI, kg/m2 0.240 0.002 0.200 0.010
SBP, mm Hg 0.159 0.032 0.0139 0.854
DBP, mm Hg 0.088 0.234 0.056 0.455
Glucose, mg/dL 0.278 0.001 0.193 0.009
Total cholesterol, mg/dL 0.051 0.494 0.074 0.320
HDL cholesterol, mg/dL 0.016 0.837 0.013 0.859
LDL cholesterol, mg/dL 0.092 0.214 0.105 0.156
Triglycerides, mg/dL 0.169 0.031 0.159 0.044
O2 production, counts/s 0.293 0.001 0.248 0.001
P values for bivariate correlations. R and Pc values of partial correlations
after controlling for age and sex.
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O2 production was significantly increased in the third and
the fourth quartiles compared with the first (quartile 1:
13.61.5 counts/sec, N43; quartile 2: 17.42.1 counts/sec,
N49; quartile 3: 20.12.5 counts/sec, N45; quartile 4:
23.13.9 counts/sec, N47).
Discussion
In a population sample of middle-aged adults free of clini-
cally evident atherosclerotic disease, the main finding of this
study is that phagocytic NADPH oxidase–dependent O2
production showed a significant correlation with carotid IMT,
an index of subclinical atherosclerosis, independently of a
wide range of important confounding variables, including
some conventional cardiovascular risk factors. Oxidative
stress mediated by NADPH oxidase systems plays an unfa-
vorable effect on the thickening of the arterial wall, contrib-
uting to the initiation and development of the atherosclerotic
lesion. Despite not having determined other sources of
oxidative stress, our data suggest that phagocytic NADPH
oxidase may account for part of these effects.
Carotid IMT indicates the status of the vascular wall and is
a useful method to study atherosclerotic disease. Carotid IMT
has been correlated with cardiovascular risk factors, such as
age, hypertension, hypercholesterolemia, and smoking, asso-
ciated with the development of atherosclerosis in any vascu-
lar bed.21 Available evidence substantiates that carotid IMT
correlates positively with coronary and peripheral atheroscle-
rosis. Craven et al17 demonstrated that a measure of carotid
IMT was strongly and independently associated with coro-
nary artery disease in patients older than 50 years. Besides,
carotid IMT represents an independent risk factor for athero-
thrombotic events.18–20 Moreover, an increase of 1 standard
deviation in IMT measurement was associated with a 1.36
relative risk for the combined end point of myocardial
infarction or stroke.25 Taken together, these studies demon-
strate that carotid IMT correlates with atherosclerosis and
represents an independent risk factor for coronary heart
disease events, stroke, and transient cerebral ischemia, thus
providing a useful surrogate marker for atherosclerotic
disease.21
The NADPH oxidase systems constitute the most impor-
tant source of O2 in the cells of the vessel wall.4 Vascular
NADPH oxidase isoforms are similar, although they differ
from the phagocytic NADPH oxidase system. In the past
years, it has been reported a significant involvement of
vascular NADPH oxidases in the pathophysiology of vascular
wall. Overexpression of Nox homologues in fibroblasts
suggests that Nox1 has mitogenic activity and is growth-
promoting,6 whereas Nox4 decreased the rate of cell prolif-
eration and is implicated in cellular senescence.7 In VSMC,
Nox1 is upregulated by proliferative stimuli, such as angio-
tensin II and platelet-derived growth factor, whereas Nox4 is
downregulated by these agonists26 and by proinflammatory
mediators, such as IL-1 and thrombin.27 In endothelial cells,
Nox4 is upregulated by serum removal and downregulated by
addition of serum.10 In a model of restenosis, the expression
of Nox1, Nox2, and p22phox is elevated early after injury,
whereas Nox4 increases later,28 coinciding with a reduction in
the rate of VSMC proliferation. Inhibition of Nox2-dependent
NADPH oxidase suppresses angioplasty-induced superoxide
and neointimal hyperplasia of rat carotid artery.29 Collec-
tively, Nox1 and Nox2 are involved in acute response to
injury or to proliferative stimulation, whereas Nox4 is in-
volved in maintaining the quiescent phenotype. In contrast to
Nox2 and Nox4, the importance of Nox1 in human vessels is
less clear, because very low levels of expression have been
detected in coronary arteries,14 and in mammary artery and
saphenous vein.9
During the past decade, it has been shown an essential role
of NADPH oxidases in the development of atherosclerosis.
Guzik et al11 showed that vascular NADPH oxidases are
major sources of O2 in human vessels and showed an
association between enzymatic activity and clinical risk
factors in atherosclerosis. Besides, this increase in NADPH
oxidase activity impaired endothelium-dependent vasodila-
tion in atherosclerotic patients. Azumi et al12 found that the
severity of atherosclerotic lesion correlated with p22phox
overexpression in coronary arteries. Sorescu et al14 demon-
strated that Nox4 was increased in early lesions during the
TABLE 4. Correlation of the Carotid IMT With NADPH
Oxidase–Dependent O2 Production in Multiple Linear
Regression Analysis
Independent Variables b P* Partial R2, %
O2 production, counts/sec 0.0019 0.001 14.3
Age, y 0.0046 0.001 12.1
Sex, F/M 0.0289 0.268 0.9
BMI, kg/m2 0.0033 0.167 0.6
Triglycerides, mg/dL 0.0003 0.251 0.2
SBP, mm Hg 0.0002 0.761 0
Glucose, mg/dL 0.0002 0.635 0
Smokers, no/yes 0.0357 0.109 0
*Adjusted for age, sex, BMI, SBP, triglycerides, glucose, and smoking.
R2 for the total population was 28.1%
Figure 2. Phagocytic NADPH oxidase–dependent O2 produc-
tion according to the quartiles of carotid IMT. q1, IMT 0.6 mm;
q2, IMT 0.6 and 0.7 mm; q3, IMT 0.7 and 0.8 mm; q4,
IMT 0.8 mm. Data are expressed as meanSEM. *P0.05
compared with q1; q indicates quartile.
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atheroma stage of the plaque and decreased in more advanced
stages of lesions in coronary arteries, whereas Nox2 and
p22phox were greatly increased along the progression of human
atherosclerotic plaques, thus suggesting a possible causal link
between the classic NADPH oxidase and the development of
lesions. Interestingly, the contribution of Nox2 to lesion
progression was caused almost entirely by infiltrated mono-
cytes.13,14 In fact, preactivated monocytes exhibit higher
cytokine production and greater adherence to the vascular
wall,30,31 and play a role in the oxidative stress-mediated
pathogenesis of atherosclerosis.32 Moreover, NADPH oxi-
dase–derived O2 production from infiltrated monocytes may
contribute to atherosclerotic lesion formation.16 Thus, our
study showing a substantial increase in NADPH oxidase–
dependent O2 formation in phagocytic cells from subjects
with higher values of IMT adds new insights into the
contributing role of the phagocytic NADPH oxidase system
in the initiation and progression of human atherosclerosis.
The significance of our data are underlined by a study
showing that ROS production spatially associated with the
distribution of p22 phox and oxidized low-density lipoprotein
in atherosclerotic human coronary arteries.15 Although
VSMCs and fibroblasts participated in ROS generation, these
species were mainly generated by infiltrated inflammatory
cells.15 Moreover, ROS production was significantly higher
in unstable versus stable angina pectoris, which suggests that
ROS might also modulate plaque stability.15 Collectively,
these studies support the possibility that both phagocytic and
vascular NADPH oxidase systems may play an essential role
in the development and progression of atherosclerotic lesion.
This hypothesis is underlined by a genetic study showing that
deletion of the NADPH oxidase subunit p47phox gene reduces
the area of atherosclerosis in the descending aorta of apoli-
poprotein E/ knockout mice.33
Our findings showing that phagocytic NADPH oxidase–
dependent O2 production explained up to 14.3% of the
carotid IMT variance after adjusting for the effect of common
risk factors, suggest that vascular NADPH oxidase isoforms
may be also participating in the atherosclerotic process.11–15
Furthermore, we should take into account that several enzy-
matic origins have been proposed as sources of ROS in
atherosclerotic process other than NADPH oxidases, such as
lipoxygenase, xanthine oxidase, and nitric oxide synthase.34 It
has also been highlighted the impact of age as a major
determinant of carotid IMT.35 Likewise, the influence of age
on carotid IMT was similarly strong (12.1%) in our survey,
even after adjusting for phagocytic NADPH oxidase–medi-
ated O2 production.
An important number of potential stimulating factors of the
NADPH oxidase system may be related to increased phago-
cytic O2 production in the setting of cardiovascular diseases.
Several humoral factors, including angiotensin II, endothelin
1, and some cytokines, stimulate the phagocytic NADPH
oxidase activity.36–39 Likewise, our study reported that angio-
tensin II and endothelin 1 stimulated O2 production in
phagocytic cells. In addition, several polymorphisms of
CYBA, the human gene that encodes the p22phox subunit, play
a functional role on the NADPH oxidase activity.22,40,41
Overall, our findings suggest that increased phagocytic
NADPH oxidase activity may represent a potential indicator
of oxidation occurring in the vascular wall of asymptomatic
subjects. Because the present study does not provide direct
evidence of the potential role of the vascular NADPH oxidase
isoforms, it is important to point out that the increased
phagocytic NADPH oxidase– dependent O2 production
might not necessarily be the main culprit of the increased
carotid IMT but may be simply a harbinger of the activation
of vascular NADPH oxidase isoforms. Moreover, our data
showing that phagocytes respond to the same circulating
factors that are also directly stimulating the vascular NADPH
oxidase homologues lead us to consider the possibility that
phagocytic NADPH oxidase activation might be the reflec-
tion of the oxidation occurring in the vasculature.
One limitation of the study is that the cross-sectional
analysis and the small sample size restrict our interpretation
of the results, which represent a potential bias for complex
multifactorial analysis. Because few women and no elderly
individuals were included, results cannot be extrapolated to
such populations at risk of cardiovascular disease. Another
limitation is the lack of standardized ultrasound protocols for
the measurement and interpretation of carotid IMT.23 To
obtain accurate measurements of carotid IMT, the same 2
certified sonographers performed ultrasound examination
along our study. Finally, the unavailability of vascular tissue
biopsies that would allow us to identify which NADPH
oxidase system is in fact involved in the thickening of
vascular wall constitutes another limitation.
In summary, we found that increased phagocytic NADPH
oxidase–dependent O2 production is associated with en-
hanced carotid IMT in subjects without clinically overt
atherosclerotic disease. Because carotid IMT correlates with
atherosclerosis, our study supports that activation of phago-
cytic NADPH oxidase significantly associates with the ath-
erosclerotic process in these subjects. The relevance of our
findings is underlined by the significant role that oxidative
stress plays in the initiation, progression, and the end event of
the atherosclerotic process.
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